Showing 1 - 10 of 13
Persistent link: https://www.econbiz.de/10010848781
<Emphasis Type="Bold">Background: About 7% of children and adolescents are diagnosed with attention-deficit/hyperactivity disorder (ADHD) in the US. Patients with ADHD who are intolerant of or do not have an optimal response to stimulants often use non-stimulants as alternative therapies. Guanfacine extendedrelease...</emphasis>
Persistent link: https://www.econbiz.de/10011000747
Persistent link: https://www.econbiz.de/10011000750
The impairment associated with residual ADHD symptoms after stimulant therapy is becoming increasingly recognized. This is the first analysis of the cost effectiveness of stimulants combined with an adjunctive medication. This study suggests that the adjunctive therapy of GXR with stimulants is...
Persistent link: https://www.econbiz.de/10011001572
Conventional anticoagulants were most commonly used in the study sample. Under-monitoring and suboptimal care may be an issue for patients treated with warfarin. The average total inpatient cost of VTE-related hospitalizations is high. </AbstractSection> Copyright Springer International Publishing Switzerland 2014
Persistent link: https://www.econbiz.de/10011001687
This study suggests that hospitals can realize cost savings by substituting L-AMB for ABLC in the treatment of IFIs. The cost savings are driven by the lower rates of AEs associated with L-AMB use compared with ABLC. </AbstractSection> Copyright Springer International Publishing Switzerland 2014
Persistent link: https://www.econbiz.de/10011000708
The absence of head-to-head trials is a common challenge in comparative effectiveness research and health technology assessment. Indirect cross-trial treatment comparisons are possible, but can be biased by cross-trial differences in patient characteristics. Using only published aggregate data,...
Persistent link: https://www.econbiz.de/10011001483
<Emphasis Type="Bold">Objective: To determine and compare the cost utilities of the tumour necrosis factor (TNF) antagonists adalimumab and infliximab as maintenance therapies for patients in the US with moderately to severely active Crohn’s disease. <Emphasis Type="Bold">Methods: Maintenance regimens of adalimumab (40 mg every other...</emphasis></emphasis>
Persistent link: https://www.econbiz.de/10011001569
The current research examines the effects of time pressure on decision behavior based on a prospect theory framework. In Experiments 1 and 2, participants estimated certainty equivalents for binary gains-only bets in the presence or absence of time pressure. In Experiment 3, participants...
Persistent link: https://www.econbiz.de/10010572118
This article aims to demonstrate how innovative testing practices can effectively prevent high-tech mass cheating and improve fairness in language assessment. The article first introduces Xi's (2010) view of validity and fairness and her proposal of an argument-based approach to empirically...
Persistent link: https://www.econbiz.de/10012043443